US COVID-19 blood plasma trial halted by NIH
A clinical trial run by the National Institutes of Health exploring the efficacy of convalescent plasma in treating mild to moderate COVID-19 patients has been halted. The once-promising treatment was deemed unlikely to be of any benefit and follows on… Continue reading US COVID-19 blood plasma trial halted by NIH
